60 mcg/30 mcg recombinant hepatitis B vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 60 mcg/30 mcg recombinant hepatitis B vaccine, covering 2012-04-23 to 2012-04-23. Get the full timeline:
Most recent: Clinical Trial Update: The Immunogenicity and Safety of 60mcg/30mcg Recombinant Hepatitis B Vaccines in People Who Failed to Respond to Routine Administration of Hepatitis B Vaccines [Phase 2, Phase 3]